iRhythm Technologies (NASDAQ:IRTC - Get Free Report) CAO Marc Wade Rosenbaum sold 226 shares of the stock in a transaction dated Monday, August 11th. The shares were sold at an average price of $158.93, for a total transaction of $35,918.18. Following the transaction, the chief accounting officer owned 10,879 shares of the company's stock, valued at approximately $1,728,999.47. The trade was a 2.04% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.
iRhythm Technologies Price Performance
Shares of IRTC stock traded up $1.79 during trading hours on Tuesday, reaching $162.35. The stock had a trading volume of 451,993 shares, compared to its average volume of 475,277. The stock's fifty day simple moving average is $144.81 and its 200 day simple moving average is $124.79. The company has a current ratio of 5.02, a quick ratio of 4.88 and a debt-to-equity ratio of 6.25. iRhythm Technologies has a 12 month low of $55.92 and a 12 month high of $168.32. The firm has a market capitalization of $5.22 billion, a PE ratio of -55.41 and a beta of 1.41.
iRhythm Technologies (NASDAQ:IRTC - Get Free Report) last released its quarterly earnings data on Thursday, July 31st. The company reported ($0.32) EPS for the quarter, beating analysts' consensus estimates of ($0.53) by $0.21. iRhythm Technologies had a negative net margin of 14.06% and a negative return on equity of 90.03%. The company had revenue of $186.69 million during the quarter, compared to analyst estimates of $173.94 million. During the same period last year, the business earned ($0.61) earnings per share. iRhythm Technologies's revenue was up 26.1% compared to the same quarter last year. On average, equities research analysts predict that iRhythm Technologies will post -1.98 EPS for the current year.
Analysts Set New Price Targets
Several equities analysts recently weighed in on IRTC shares. William Blair upgraded shares of iRhythm Technologies to a "strong-buy" rating in a research report on Friday, August 1st. Canaccord Genuity Group increased their target price on shares of iRhythm Technologies from $139.00 to $170.00 and gave the stock a "buy" rating in a research report on Friday, August 1st. Robert W. Baird increased their target price on shares of iRhythm Technologies from $133.00 to $150.00 and gave the stock an "outperform" rating in a research report on Friday, May 2nd. Citigroup increased their target price on shares of iRhythm Technologies from $130.00 to $167.00 and gave the stock a "buy" rating in a research report on Thursday, May 22nd. Finally, Wells Fargo & Company increased their target price on shares of iRhythm Technologies from $130.00 to $180.00 and gave the stock an "overweight" rating in a research report on Friday, August 1st. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $157.30.
Check Out Our Latest Analysis on IRTC
Hedge Funds Weigh In On iRhythm Technologies
A number of large investors have recently modified their holdings of IRTC. Ameritas Investment Partners Inc. raised its stake in iRhythm Technologies by 2.9% in the second quarter. Ameritas Investment Partners Inc. now owns 3,256 shares of the company's stock valued at $501,000 after purchasing an additional 93 shares in the last quarter. Xponance Inc. raised its stake in iRhythm Technologies by 6.1% in the first quarter. Xponance Inc. now owns 2,390 shares of the company's stock valued at $250,000 after purchasing an additional 137 shares in the last quarter. Hsbc Holdings PLC raised its stake in iRhythm Technologies by 3.1% in the first quarter. Hsbc Holdings PLC now owns 4,590 shares of the company's stock valued at $474,000 after purchasing an additional 138 shares in the last quarter. CWM LLC raised its stake in iRhythm Technologies by 54.3% in the first quarter. CWM LLC now owns 517 shares of the company's stock valued at $54,000 after purchasing an additional 182 shares in the last quarter. Finally, Bank Pictet & Cie Europe AG raised its stake in iRhythm Technologies by 5.9% in the fourth quarter. Bank Pictet & Cie Europe AG now owns 3,289 shares of the company's stock valued at $297,000 after purchasing an additional 184 shares in the last quarter.
iRhythm Technologies Company Profile
(
Get Free Report)
iRhythm Technologies, Inc, a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider iRhythm Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and iRhythm Technologies wasn't on the list.
While iRhythm Technologies currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.